Eli Lilly and Co
LLY
NYSE
Pharmaceuticals
$1244.40
USD
-35.94 (-2.81%)
At close: Aug 20, 2026, 4:00 PM EDT
Market Cap $1.15T
Volume 2.4M
Price Target
$1232.00 – $1410.00
USD
The 5 analysts offering 1-year price forecasts have a max estimate of $1410.00 and a min estimate of $1232.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$1303.20
+$70.8 vs prior
Implied Upside
+4.7%
+5.7% vs prior
Analyst Covering
5
-3 vs prior period
Consensus
Buy
Improved vs prior
Signal Quality
Consensus Freshness
38%
Many ratings are older - consensus may be less current
Analyst Agreement
High
Targets are closely clustered - analysts agree more than usual
Mean vs Median
$30 Gap
Median $1273.00 vs avg $1303.20 - a few bullish outliers are pulling the average up
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
5 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
5
Hold
0
Sell
0
Strong Sell
0
5 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Carter Gould | Cantor Fitzgerald | Buy | Maintained | 2 weeks ago | Plus | Plus | Plus |
Seamus Fernandez | Guggenheim | Buy | Maintained | 1 month ago | Plus | Plus | Plus |
David Risinger | Leerink Partners | Buy | Maintained | 1 month ago | Plus | Plus | Plus |
Akash Tewari | Jefferies | Buy | Maintained | 2 months ago | Plus | Plus | Plus |
Jason Gerberry | B of A Securities | Buy | Maintained | 2 months ago | Plus | Plus | Plus |
Frequently Asked Questions
